Analyst Price Targets — HOPE
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 28, 2026 1:21 pm | Gary Tenner | D.A. Davidson | $16.00 | $14.17 | TheFly | Hope Bancorp price target raised to $16 from $15 at DA Davidson |
| October 29, 2025 1:28 pm | Gary Tenner | D.A. Davidson | $14.50 | $10.99 | StreetInsider | Hope Bancorp (HOPE) PT Raised to $14.50 at DA Davidson |
| July 30, 2024 8:27 am | Gary Tenner | D.A. Davidson | $15.00 | $13.17 | StreetInsider | Hope Bancorp (HOPE) PT Raised to $15 at DA Davidson |
| April 30, 2024 6:12 am | Gary Tenner | D.A. Davidson | $12.50 | $9.93 | StreetInsider | DA Davidson Upgrades Hope Bancorp (HOPE) to Buy |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for HOPE

LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (NASDAQ: HOPE) today announced that its wholly-owned subsidiary, Bank of Hope, has received all regulatory approvals required to complete the previously announced acquisition of the Commercial Banking Unit of SMBC MANUBANK (“MANUBANK”), a wholly owned subsidiary of SMBC Americas Holdings, Inc. and Sumitomo Mitsui Banking Corporation (“SMBC”). Regulatory approvals have…

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUSÂ platform to develop in vivo gene editi

--Independent Peer Review Provides External Validation of the Trial's Design, Statistical Methodology and Findings-- --Randomized, Double-Blind, Placebo-Controlled HOPE-3 Phase 3 Trial (n=106) Met Primary Endpoint, with Deramiocel Slowing Upper Limb Function Decline by 54 Percent versus Placebo (PUL 2.0, p=0.03) and Showing Clinically Meaningful Cardiac Benefit--

Hope Bancorp delivered a strong Q2 2026, with revenue and adjusted EPS both exceeding analyst expectations and a swing from loss to profit. HOPE's net interest margin expanded to 2.96%, deposits and loans grew, and non-interest income rebounded sharply due to the absence of prior-year securities losses. Despite trading below book value, HOPE's forward P/E of 13.8 and subpar asset quality (ROA 0.71%, ROE 5.76%) limit…

NEW YORK--(BUSINESS WIRE)--Bank of Hope, subsidiary of Hope Bancorp, Inc. (NASDAQ: HOPE), is expanding the ways it connects with customers and community members through a creative branding campaign centered on a sponsorship of 'BTS THE CITY ARIRANG NEW YORK'. Celebrating ‘BTS THE CITY ARIRANG NEW YORK' as people from around the world gather in New York City, this campaign serves as a unique activation targeted at…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for HOPE.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
